Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a mesenchymal giant cell tumor at the tibia expressing Periostin

被引：0
|
作者：
Hautmann, A. H. [1 ]
Schroeder, J. [2 ]
Wild, P. [3 ]
Hautmann, M. [4 ]
Hoffstetter, P. [5 ]
Girlich, C. [6 ]
Fleck, M. [7 ]
机构：
[1] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 3, Regensburg, Germany
[2] Univ Klinikum Regensburg, Inst Pathol, Regensburg, Germany
[3] Univ Klinikum Zurich, Inst Pathol, Zurich, Switzerland
[4] Univ Klinikum Regensburg, Klin & Poliklin Strahlentherapie, Regensburg, Germany
[5] Asklepios Clin, Inst Radiol, Bad Abbach, Germany
[6] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany
[7] Univ Klinikum Regensburg, Asklepios Klin Bad Abbach, Klin & Poliklin Rheumatol & Klin Immunol, Klin & Poliklin Innere Med 1, Regensburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P495
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [1] Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
    Hautmann, Anke H.
    Schroeder, Josef
    Wild, Peter
    Hautmann, Matthias G.
    Huber, Elisabeth
    Hoffstetter, Patrick
    Fleck, Martin
    Girlich, Christiane
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2014, 2014
  • [2] TUMOR-INDUCED OSTEOMALACIA CAUSED BY A FGF-23 PRODUCING MESENCHYMAL TUMOR
    Hu, Sophia
    Lubitz, Sara
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S460 - S460
  • [3] FGF-23 protein is present in normal plasma and is increased in patients with tumor-induced osteomalacia.
    Yamazaki, Y
    Shibata, M
    Okazaki, R
    Takeuchi, Y
    Fujita, T
    Yamashita, T
    Fukumoto, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S159 - S159
  • [4] TUMOR-INDUCED OSTEOMALACIA (TIO) WITH ELEVATED FGF-23 CAUSING HYPOPHOSPHATEMIA IN OVARIAN MALIGNANCY
    Paster, L.
    Mastroianni, F.
    Ross, D.
    Feldhamer, K.
    Wanchoo, R.
    Jhaveri, K. D.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A65 - A65
  • [5] A Normal FGF23 Does Not Preclude Tumor-Induced Osteomalacia
    Nandam, Neeharika
    Ejaz, Sadia
    Ahrens, William
    Styner, Maya
    [J]. JBMR PLUS, 2021, 5 (02)
  • [6] A SERIES OF FGF23-PRODUCING TUMOR-INDUCED OSTEOMALACIA CASES
    Grebennikova, T.
    Belaya, Z.
    Rozhinskaya, L.
    Slashchuk, K.
    Degtyarev, M.
    Kulikova, K.
    Przhiyalkovskaya, E.
    Tsoriev, T.
    Mamedova, E.
    Pigarova, E.
    Gronskaya, S.
    Vladimirova, V.
    Tarbaeva, N.
    Boulytcheva, I.
    Merkulov, M.
    Rodionova, S.
    Rumyantsev, P.
    Melnichenko, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S471 - S471
  • [7] Cinacalcet is associated with decreased serum FGF-23 and improved phosphorous homeostasis in patients with tumor-induced osteomalacia.
    Geller, JL
    Cutler, C
    Kelly, MH
    Adams, JS
    Collins, MT
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S177 - S177
  • [8] A Case of Tumor-Induced Osteomalacia (TIO) with Paradoxical Fibroblast Growth Factor 23 (FGF-23) Response After Surgical Excision
    Rahim, Shab E. Gul
    Epstein, David L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 789 - 789
  • [9] Tumor-induced Osteomalacia Secondary to Phosphaturic Mesenchymal Tumor
    Agarwal, Amit
    Bathla, Girish
    Gupta, Vivek
    [J]. RADIOLOGY-IMAGING CANCER, 2023, 5 (02):
  • [10] Paraneoplastic Osteomalacia due to a rare FGF-23 secreting Tumor
    Kurktschiev, Peter
    Beckmann, Johannes
    Weinhart, Philipp
    Schumm-Draeger, Petra-Maria
    Steinmetz, Armin
    [J]. INNERE MEDIZIN, 2024, 65 : S28 - S29
12345